Title |
Liraglutide Increases FGF-21 Activity and Insulin Sensitivity in High Fat Diet and Adiponectin Knockdown Induced Insulin Resistance
|
---|---|
Published in |
PLOS ONE, November 2012
|
DOI | 10.1371/journal.pone.0048392 |
Pubmed ID | |
Authors |
Mengliu Yang, Lili Zhang, Chong Wang, Hua Liu, Guenther Boden, Gangyi Yang, Ling Li |
Abstract |
Liraglutide is a glucagon-like peptide-1 analogue that stimulates insulin secretion and improves β-cell function. However, it is not clear whether liraglutide achieves its glucose lowering effect only by its known effects or whether other as yet unknown mechanisms are involved. The aim of this study was to examine the effects of liraglutide on Fibroblast growth factor-21 (FGF-21) activity in High-fat diet (HFD) fed ApoE(-/-) mice with adiponectin (Acrp30) knockdown. |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
China | 1 | 2% |
Unknown | 57 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 20% |
Researcher | 11 | 19% |
Student > Bachelor | 8 | 14% |
Student > Master | 5 | 8% |
Student > Doctoral Student | 3 | 5% |
Other | 10 | 17% |
Unknown | 10 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 29% |
Agricultural and Biological Sciences | 12 | 20% |
Biochemistry, Genetics and Molecular Biology | 7 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 10% |
Neuroscience | 2 | 3% |
Other | 4 | 7% |
Unknown | 11 | 19% |